Quality of life study for patients with neuroendocrine tumors getting internal radiation therapy
Part of Cancer clinical trials.
This study looks at how internal radiation therapy (RIV) affects quality of life in people with neuroendocrine tumors. It aims to understand how well patients tolerate this treatment and how it impacts daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are starting a treatment called RIV (internal radiation therapy) for a neuroendocrine tumor, and your doctor has approved this treatment.
- You have received information about the study and agreed to take part.
- You are not in prison or under a legal guardianship that takes away your freedom to choose.
- You can join this study even if you are getting RIV again after previous treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with neuroendocrine tumors tolerate oral (pill) anti-cancer drugs and how these drugs affect their quality of life. It also tests a patient education program to help manage side effects and improve well-being.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This study is tracking patients with advanced neuroendocrine tumors to see which treatments help them live longer without severe side effects, and how these side effects affect daily life. It aims to find the best treatment approaches for people like you.
This study collects information about how you feel and how treatment is delivered while you receive radiotherapy using the RefleXion Medical radiotherapy system. It may help doctors improve care and better understand what affects quality of life during treatment.
This study looks at how people feel about their decision to have radiation therapy, and how it affects their quality of life. By answering questionnaires, you can help doctors better support patients in similar situations.
This trial studies how well people do—especially their quality of life—after SBRT radiation for primary kidney cancer that can’t be removed with surgery. It may help doctors understand which patients benefit most and what side effects to expect.
Hear when a new Metastatic Neuroendocrine Tumour trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.